Yemarshet K. Gebreyohannes - Publications

In Vivo Evaluation of Fibroblast Growth Factor Receptor Inhibition in Mouse Xenograft Models of Gastrointestinal Stromal Tumor.

Journal: Biomedicines

Published: February 15, 2022

Plocabulin, a novel tubulin inhibitor, has potent antitumor activity in patient-derived xenograft models of gastrointestinal stromal tumors.

Journal: Translational oncology

Published: April 14, 2020

Differential antitumor activity of compounds targeting the ubiquitin-proteasome machinery in gastrointestinal stromal tumor (GIST) cells.

Journal: Scientific reports

Published: September 26, 2019

Assessment of the platelet-derived growth factor receptor alpha antibody olaratumab in a panel of patient-derived soft tissue sarcoma xenografts.

Journal: BMC cancer

Published: March 20, 2019

Anti-tumor activity of the MDM2-TP53 inhibitor BI-907828 in dedifferentiated liposarcoma patient-derived xenograft models harboring MDM2 amplification.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: March 02, 2019

Establishment and Characterization of Histologically and Molecularly Stable Soft-tissue Sarcoma Xenograft Models for Biological Studies and Preclinical Drug Testing.

Journal: Molecular cancer therapeutics

Published: September 13, 2018

PLX9486 shows anti-tumor efficacy in patient-derived, tyrosine kinase inhibitor-resistant KIT-mutant xenograft models of gastrointestinal stromal tumors.

Journal: Clinical and experimental medicine

Published: July 05, 2018

Robust Activity of Avapritinib, Potent and Highly Selective Inhibitor of Mutated KIT, in Patient-derived Xenograft Models of Gastrointestinal Stromal Tumors.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 13, 2018

Anagrelide for Gastrointestinal Stromal Tumor.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 12, 2018

New targets and therapies for gastrointestinal stromal tumors.

Journal: Expert review of anticancer therapy

Published: November 08, 2017

A precision therapy against cancers driven by KIT/PDGFRA mutations.

Journal: Science translational medicine

Published: June 23, 2017

Volatile organic compounds in gastrointestinal stromal tumour tissue originating from patient-derived xenografts.

Journal: Journal of breath research

Published: April 19, 2017